Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

MK-386 lowers DHT in blood and skin but not in semen.

Naringenin and its combination with minoxidil significantly improved hair growth in mice.

Necrostatin-1s can promote hair growth and may help treat hair loss.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

Isoliensinine, a natural compound, prevents stress-related hair greying by blocking a specific receptor on hair cells.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

N-oxides are important in medicine for improving drug properties and targeting.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

A new engineered treatment shows promise in curing heart fibrosis.

Some dibenzo compounds might help treat cancer with fewer side effects.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Minoxidil-loaded nanostructured lipid carriers are effective for topical use.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Olanzapine reduces stress-related anxiety in rats when given acutely.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Allopregnanolone affects fear responses differently in male and female rats, possibly explaining sex differences in anxiety disorders.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Neurotrophins are important for hair growth and could help treat hair loss.

Finasteride may help reduce impulsivity caused by pramipexole.